| Literature DB >> 29479840 |
Ana I Hernandez Cordero1, Peter Carbonetto2, Gioia Riboni Verri1, Jennifer S Gregory1, David J Vandenbergh3, Joseph P Gyekis4, David A Blizard3, Arimantas Lionikas1.
Abstract
The genetics underlying variation in health-related musculoskeletal phenotypes can be investigated in a mouse model. Quantitative trait loci (QTLs) affecting musculoskeletal traits in the LG/J and SM/J strain lineage remain to be refined and corroborated. The aim of this study was to map muscle and bone traits in males (n = 506) of the 50th filial generation of advanced intercross lines (LG/SM AIL) derived from the two strains. Genetic contribution to variation in all musculoskeletal traits was confirmed; the SNP heritability of muscle mass ranged between 0.46 and 0.56; and the SNP heritability of tibia length was 0.40. We used two analytical software, GEMMA and QTLRel, to map the underlying QTLs. GEMMA required substantially less computation and recovered all the QTLs identified by QTLRel. Seven significant QTLs were identified for muscle weight (Chr 1, 7, 11, 12, 13, 15, and 16), and two for tibia length, (Chr 1 and 13). Each QTL explained 4-5% of phenotypic variation. One muscle and both bone loci replicated previous findings; the remaining six were novel. Positional candidates for the replicated QTLs were prioritized based on in silico analyses and gene expression in muscle tissue. In summary, we replicated existing QTLs and identified novel QTLs affecting muscle weight, and replicated bone length QTLs in LG/SM AIL males. Heritability estimates substantially exceed the cumulative effect of the QTLs, hence a richer genetic architecture contributing to muscle and bone variability could be uncovered with a larger sample size.Entities:
Keywords: zzm321990QTLzzm321990; Bone; Skeletal muscle; gene expression
Mesh:
Year: 2018 PMID: 29479840 PMCID: PMC6430048 DOI: 10.14814/phy2.13561
Source DB: PubMed Journal: Physiol Rep ISSN: 2051-817X
Proportion of variance in muscle and bone traits explained by measured genetic variants in LG/SM AIL male mice
| Traits | SNP heritability ± SE | Mean ± SD ( |
|---|---|---|
| TA, mg | 0.56 ± 0.06 | 45.7 ± 4.9 |
| EDL, mg | 0.51 ± 0.06 | 8.5 ± 1.0 |
| Gastroc, mg | 0.45 ± 0.06 | 107.1 ± 12.0 |
| Soleus, mg | 0.46 ± 0.06 | 6.7 ± 1.0 |
| Tibia length, mm | 0.40 ± 0.06 | 16.4 ± 0.5 |
Columns form left to right: (1) trait investigated and units; (2) proportion of phenotypic variance explained by the 7,236 available genetic markers on autosomal chromosomes and X chromosome (“SNP heritability”) and standard error for the SNP heritability estimates. (3) Sample mean and standard deviation of the phenotype.
Figure 1Empirical distribution of traits investigated in LG/SM AIL male mice. Blue histograms represent muscle traits. Tibialis anterior (TA), extensor digitorum longus (EDL), gastrocnemius (Gastroc) and soleus weights differ greater than twofold between the most and least muscular animals. Green histogram represent tibia.
Sample correlations (r) among all traits measured in the LG/SM AIL
| Trait | TA | EDL | Gastroc | Soleus | Tibia |
|---|---|---|---|---|---|
| TA | 1.00 | 0.80 | 0.79 | 0.60 | 0.65 |
| EDL | 1.00 | 0.81 | 0.61 | 0.64 | |
| Gastroc | 1.00 | 0.67 | 0.66 | ||
| Soleus | 1.00 | 0.49 | |||
| Tibia | 1.00 |
TA, tibialis anterior; EDL, extensor digitorum longus; Gastroc, gastrocnemius.
Figure 2Comparison of LOD scores at all 7236 candidate SNPs computed using QTLRel and GEMMA. Horizontal and vertical dashed lines depict significance thresholds (α = 0.05) for QTLRel and GEMMA LOD scores, respectively.
Figure 3Genome‐wide scans for TA, EDL, gastrocnemius and soleus muscle weight (blue), and Tibia length (green). The vertical axes show the GEMMA LOD scores for the 7236 polymorphic SNPs arranged by their chromosomal positions in the horizontal axis. The horizontal blue line represents threshold at α = 5%.
Quantitative trait loci affecting muscle weights and tibia length in LG/SM AIL male mice
| QTL | Chr | QTL region, Mb | Top SNP, Mb | Trait | Genes | Size, Mb | LOD | PVE (%) | Mean trait (mg) LG/Het/SM |
|
|
| Ref |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
| 1 | 85.4–88.6 | 89.4 | TA | 132 | 3.1 | 5.19 | 4.0 | 45.5/45.9/46.2 | −1.34 | −1.39 | 0.13 | |
| 1 | 85.4–87.9 | 85.4 | EDL | 2.5 | 4.38 | 3.2 | 8.5/8.6/8.5 | −0.27 | −0.22 | 0.07 | |||
|
| 1 | 85.4–87.9 | 87.8 | Tibia | 100 | 2.5 | 6.30 | 3.3 | 16.5/16.4/16.2 | 0.19 | 0.16 | −0.02 | (Norgard et al. |
|
| 7 | 106.0–115.0 | 114.0 | EDL | 241 | 9.0 | 5.07 | 5.5 | 8.6/8.6/8.2 | 0.23 | 0.24 | 0.08 | (Lionikas et al. |
|
| 11 | 109.4–112.1 | 110.3 | TA | 31 | 2.7 | 4.65 | 2.3 | 45.1/46.2/46.9 | −1.25 | −0.89 | 0.60 | |
| 11 | 111.0–111.8 | 111.2 | EDL | 0.8 | 7.79 | 6.2 | 8.3/8.7/8.9 | −0.34 | −0.31 | −0.01 | |||
|
| 12 | 7.7–10.4 | 10.0 | Gastroc | 45 | 2.7 | 5.06 | 3.4 | 110.0/107.1/105.1 | 2.77 | 2.82 | −0.61 | |
|
| 13 | 103.0–108.0 | 105.0 | TA | 40 | 5.0 | 5.72 | 3.8 | 45.7/45.6/46.2 | −1.26 | −1.48 | −0.41 | |
| 13 | 103.0–108.0 | 105.2 | EDL | 5.0 | 6.46 | 5.5 | 8.5/8.5/8.7 | −0.29 | −0.32 | −0.09 | |||
|
| 13 | 103.0–108.0 | 105.2 | Tibia | 40 | 5.0 | 5.29 | 6.3 | 16.6/16.4/16.2 | 0.16 | 0.15 | −0.03 | (Norgard et al. |
|
| 16 | 30.9–32.9 | 32.0 | Soleus | 52 | 2.0 | 7.54 | 5.1 | 7.0/6.8/6.4 | 0.32 | 0.33 | 0.07 |
Columns form left to right: (1) QTL name, bold names are replicated QTLs; (2) QTL chromosome, (3) QTL region based on 1.5 LOD support interval (build 38); (4) SNP position within QTL region with largest LOD score; (5) Trait investigated; (6) Number of genes within each QTL; (7) QTL width based on the 1.5‐LOD support interval; (8) LOD score for the SNP with the largest score; (9) Proportion of phenotypic variance explained (PVE) by the top SNP within the 1.5 LOD support interval after removing linear effects of the covariates. (10) Average phenotypic value for the alleles LG homozygous, heterozygous, and SM homozygous. (11) GEMMA beta estimate. (12) QTLrel beta estimate for the additive component. (13) QTLrel beta estimate for the dominance component. MAF for the QTLs peak markers was >0.22. (14) Reference for QTLs replicated in past studies.
Candidate genes identified within muscle and bone QTLs in LG/SM AIL
| Trait | Gene description | Gene symbol | Gene position, bp | Nonsyn SNP | Differential expression | Locus ID |
|---|---|---|---|---|---|---|
| Tibia | DIS3 like 3′‐5′ exoribonuclease 2 |
| chr1: 86703808‐87050095 | X | Lbn1.1b | |
| Tibia | Holliday junction recognition protein |
| chr1: 88262471‐88277633 | X |
| |
| EDL | Microtubule associated monooxygenase calponin and LIM domain containing 2 |
| chr7:112225856‐112355194 | X | LG/J>SM/J |
|
| EDL | RIKEN cDNA 2310014F06 gene |
| chr7:112612560‐112680081 | SM/J>LG/J |
| |
| EDL | aryl hydrocarbon receptor nuclear translocator‐like |
| chr7:113207465‐113314122 | LG/J>SM/J |
| |
| EDL | SRY (sex determining region Y)‐box 6 |
| chr7:115470872‐116038796 | x |
| |
| Tibia | Splicing regulatory glutamine/lysine‐rich protein 1interacting protein 1 |
| chr13:104792484‐104839274 | x |
| |
| Tibia | Small integral membrane protein 15 |
| chr13:108046424‐108049146 | x |
|
Genes listed in this table are located within replicated QTLs. Candidate genes were included in this table based on the presence of a nonsynonymous SNP in their coding sequence with a predicted effect on protein function (based on Poly‐phen2 or SIFT algorithm), differential expression in TA muscle between LG/J and SM/J mice strains (P < 0.10) or their known function.
Figure 4Allele‐dependent expression of candidate genes in TA muscle of the LG/SM AIL males. Homozygous carriers of the SM/J and LG/J alleles were compared using Mann–Whitney tests. Mean and SEM. *P < 0.05 (one‐tailed), †P < 0.05 (two‐tailed) compared to SM/J expression. Number indicates sample size within the genotypic group.
Indel variants present in regulatory elements of the candidate genes
| Gene | Strain | Position (bp) | Variant | Regulatory element | Identifier |
|---|---|---|---|---|---|
|
| SM | chr1:86821319 | −C/−C | Promoter | ENSMUSR00000008214 |
| SM | chr1:86711651 | +GTGTGTGT/+GTGTGT | Enhancer | ENSMUSR00000298578 | |
|
| SM | chr7:112680305 | +A/+A | Promoter | ENSMUSR00000249930 |
| SM | chr7:112681671 | −A/−A | Promoter | ENSMUSR00000249930 | |
| SM | chr7:112680104 | +GCC/+GCC | Promoter | ENSMUSR00000249930 | |
| SM | chr7:112687880 | −CTTAC/−CTTAC | Enhancer | ENSMUSR00000249933 | |
| SM | chr7:112687912 | +GCGGGGA/+GCGGGGA | Enhancer | ENSMUSR00000249933 | |
| SM | chr7:112687945 | +C/+C | Enhancer | ENSMUSR00000249933 | |
| SM | chr7:112687979 | −ACTCGGAGGA/−ACTCGGAGGA | Enhancer | ENSMUSR00000249933 | |
| SM | chr7:112688431 | −TGTGTCGGC/−TGTGTCGGC | Enhancer | ENSMUSR00000249933 | |
| SM | chr7:112688537 | −C/−C | Enhancer | ENSMUSR00000249933 | |
| SM | chr7:112689921 | +TTGT/+TTGT | Enhancer | ENSMUSR00000249935 | |
| SM | chr7:112690293 | −A/−A | Enhancer | ENSMUSR00000249935 | |
|
| SM | chr7:113207721 | +CCGCCC/+CCGCCC | Promoter | ENSMUSR00000250055 |
| SM | chr7:113208434 | −CTTCACTC/−CTTCACTC | Promoter | ENSMUSR00000250055 | |
| SM | chr7:113206327 | +T/+T | Promoter | ENSMUSR00000250055 | |
| SM | chr7:113214962 | −TA/−TA | Enhancer | ENSMUSR00000250056 | |
| SM | chr7:113215089 | −TTACTA/−TTACTA | Enhancer | ENSMUSR00000250056 | |
|
| SM | chr13:108045634 | −TTTTTTT/−TTTTTTT | Promoter | ENSMUSR00000080445 |
The LG/J strain sequence was use as the reference sequence.